Reuters: Sanofi mulls nominees for Genzyme board

Suggesting that Sanofi-Aventis is prepping for a possible proxy fight at Genzyme, the French drugmaker has hired a search firm to vet for potential candidates to nominate to Genzyme's board, sources tell Reuters. Report

Suggested Articles

With momentum building in Pfizer’s gene therapy programs, it has bought a building in North Carolina where it will consolidate clinical manufacturing.

Novo Nordisk had been hoping to show its Tresiba could top Sanofi’s Toujeo in a head-to-head showdown, but it didn't quite get there.

GlaxoSmithKline won an FDA panel recommendation for its over-the-counter nicotine spray—but the backing didn’t come easy.